Trade Orgenesis Inc. - ORGS CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 0.6 |
| Open | 0.6 |
| 1-Year Change | -42.86% |
| Day's Range | 0.5 - 0.6 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 0.60 | -0.01 | -1.64% | 0.61 | 0.63 | 0.59 |
| Jul 24, 2024 | 0.61 | -0.02 | -3.17% | 0.63 | 0.64 | 0.61 |
| Jul 23, 2024 | 0.61 | -0.01 | -1.61% | 0.62 | 0.64 | 0.61 |
| Jul 22, 2024 | 0.64 | -0.04 | -5.88% | 0.68 | 0.68 | 0.61 |
| Jul 19, 2024 | 0.68 | 0.00 | 0.00% | 0.68 | 0.69 | 0.67 |
| Jul 18, 2024 | 0.68 | -0.02 | -2.86% | 0.70 | 0.70 | 0.68 |
| Jul 17, 2024 | 0.68 | 0.00 | 0.00% | 0.68 | 0.77 | 0.68 |
| Jul 16, 2024 | 0.68 | 0.00 | 0.00% | 0.68 | 0.69 | 0.67 |
| Jul 15, 2024 | 0.68 | -0.02 | -2.86% | 0.70 | 0.70 | 0.67 |
| Jul 12, 2024 | 0.67 | -0.01 | -1.47% | 0.68 | 0.82 | 0.67 |
| Jul 11, 2024 | 0.65 | 0.05 | 8.33% | 0.60 | 0.67 | 0.60 |
| Jul 10, 2024 | 0.60 | 0.00 | 0.00% | 0.60 | 0.61 | 0.59 |
| Jul 9, 2024 | 0.62 | -0.01 | -1.59% | 0.63 | 0.64 | 0.61 |
| Jul 8, 2024 | 0.61 | -0.01 | -1.61% | 0.62 | 0.64 | 0.61 |
| Jul 5, 2024 | 0.64 | 0.00 | 0.00% | 0.64 | 0.67 | 0.63 |
| Jul 3, 2024 | 0.60 | -0.01 | -1.64% | 0.61 | 0.63 | 0.60 |
| Jul 2, 2024 | 0.60 | -0.02 | -3.23% | 0.62 | 0.62 | 0.60 |
| Jul 1, 2024 | 0.62 | 0.02 | 3.33% | 0.60 | 0.65 | 0.60 |
| Jun 28, 2024 | 0.58 | -0.01 | -1.69% | 0.59 | 0.60 | 0.58 |
| Jun 27, 2024 | 0.60 | 0.00 | 0.00% | 0.60 | 0.61 | 0.58 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Orgenesis Inc. Company profile
About Orgenesis Inc
Orgenesis Inc. is a biotech company operating to unlock the potential of cell and gene therapies (CGTs). The Company is focused on autologous (using the patient’s own cells) therapies with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment. The Company has developed a Point of Care Platform comprised of three components: POCare Therapies, POCare Technologies and POCare Network. Its therapeutic portfolio pipeline is diverse and addresses various clinical needs. POCare Technology uses automated systems across a collaborative POCare Network via a combination of science, technology, engineering and networking.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Orgenesis Inc revenues increased from $5.4M to $28.6M. Net loss before extraordinary items decreased 70% to $13M. Revenues reflect POC Services segment increase from $4.3M to $17.1M, Cell process development services segment increase from $1.1M to $11.5M. Lower net loss reflects Other research and development expenses decrease of 43% to $5.6M (expense).
Equity composition
Common Stock $.001 Par, 4/13, 1.75B auth., 49,617,903 issd. Insider owns approx.50.56% Effective August 31, 2011 effected a 35 to one forward stock split
| Industry: | Medical Equipment, Supplies & Distribution (NEC) |
20271 Goldenrod Lane
GERMANTOWN
MARYLAND 20876
US
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com